Literature DB >> 2505697

Defective fibrinolysis in Behçet's syndrome: significance and possible mechanisms.

R Aitchison1, P Chu, D R Cater, R J Harris, R J Powell.   

Abstract

Reduced fibrinolytic activity has frequently been reported in Behcet's syndrome, but both the underlying mechanism and its relation to the development of thrombosis are unclear. The fibrinolytic activity was studied in seven patients with Behçet's syndrome and 12 patients with idiopathic oral ulceration. The patients with Behçet's disease had significantly reduced resting tissue plasminogen activator(t-PA) both by euglobulin fibrin plate lysis and enzyme linked immunosorbent assay (ELISA), but the tissue plasminogen activator inhibitor(t-PAI) was not significantly different from the control value. After stimulation by venous occlusion the euglobulin fibrin plate lysis results showed three good responders and four poor responders, but neither t-PA antigen nor t-PAI concentrations showed any clear difference between the two groups. Interestingly, three out of the four patients with a history of thrombosis were good responders. The group with oral ulceration showed no significant difference from the controls for any of these measurements. These findings suggest that the reduced resting fibrinolytic activity is usually due to decreased production of t-PA, but that the defective response to stimulation may be multifactorial in origin. The fibrinolytic abnormalities appear unrelated to the development of thrombosis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2505697      PMCID: PMC1003822          DOI: 10.1136/ard.48.7.590

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  4 in total

1.  Behçet's syndrome with arthritis.

Authors:  R M Mason; C G Barnes
Journal:  Ann Rheum Dis       Date:  1969-03       Impact factor: 19.103

2.  Inhibition of the fibrinolytic system in Behçet's disease?

Authors:  F Asbeck; D Meyer-Boernecke; J van de Loo
Journal:  Haemostasis       Date:  1977

3.  Abnormal fibrinolytic activity in systemic lupus erythematosus and possible mechanisms.

Authors:  P Chu; N H Russell; R J Powell; D R Cater; R J Harris
Journal:  Br J Rheumatol       Date:  1988-12

4.  Factual or artificial inhibition of fibrinolysis and the occurrence of venous thrombosis in 3 cases of Behçet's disease.

Authors:  C Kluft; J J Michiels; G Wijngaards
Journal:  Scand J Haematol       Date:  1980-11
  4 in total
  9 in total

Review 1.  Behçet's disease and thrombophilia.

Authors:  M Leiba; Y Sidi; H Gur; A Leiba; M Ehrenfeld
Journal:  Ann Rheum Dis       Date:  2001-12       Impact factor: 19.103

Review 2.  Behçet's disease.

Authors:  V Kontogiannis; R J Powell
Journal:  Postgrad Med J       Date:  2000-10       Impact factor: 2.401

Review 3.  Behçet's disease.

Authors:  T Inoue; K Satake
Journal:  Gastroenterol Jpn       Date:  1991-10

4.  Immunopathology of Behçet's disease.

Authors:  R J Powell; S Dunstan
Journal:  Postgrad Med J       Date:  1991-06       Impact factor: 2.401

Review 5.  Behçet's syndrome in pregnancy.

Authors:  Marcus Martineau; Dorian O Haskard; Catherine Nelson-Piercy
Journal:  Obstet Med       Date:  2010-03-04

6.  High lipoprotein (a) levels as a thrombogenic risk factor in Behçet's disease.

Authors:  A Orem; O Değer; O Memiş; K Calişkan; G Cimşit
Journal:  Ann Rheum Dis       Date:  1994-05       Impact factor: 19.103

7.  Behçet's Disease as a Model of Venous Thrombosis.

Authors:  Micaela La Regina; Armen Yuri Gasparyan; Francesco Orlandini; Domenico Prisco
Journal:  Open Cardiovasc Med J       Date:  2010-02-23

8.  Lp(a) lipoprotein levels as a predictor of risk for thrombogenic events in patients with Behçet's disease.

Authors:  A Orem; O Değer; O Memiş; S Bahadir; E Ovali; G Cimşit
Journal:  Ann Rheum Dis       Date:  1995-09       Impact factor: 19.103

9.  Behçet's disease: new insight into the relationship between procoagulant state, endothelial activation/damage and disease activity.

Authors:  Ihosvany Fernández-Bello; Francisco J López-Longo; Elena G Arias-Salgado; Víctor Jiménez-Yuste; Nora V Butta
Journal:  Orphanet J Rare Dis       Date:  2013-05-27       Impact factor: 4.123

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.